Zai Lab Ltd — Regulatory Filings 2020

Sep 22, 2020

6-K 1 a20-29356_96k.htm 6-K

*UNITED STATES*

*SECURITIES AND EXCHANGE COMMISSION*

*Washington, D.C. 20549*

*FORM 6-K*

*REPORT OF FOREIGN PRIVATE ISSUER*

*PURSUANT TO RULE 13A-16 OR 15D-16*

*OF THE SECURITIES EXCHANGE ACT OF 1934*

*For the month of September 2020*

*Commission Filing Number: 001-38205*

*ZAI LAB LIMITED*

(Translation of registrant’s name into English)

*4560 Jinke Road, Bldg. 1, 4F, Pudong, Shanghai, China 201210*

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F: Form 20-F x Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

SEQ.=1,FOLIO='',FILE='C:\JMS\108202\20-29356-9\task9883425\29356-9-ba.htm',USER='108202',CD='Sep 22 11:38 2020'

*EXHIBIT INDEX*

Exhibit No.	Description
99.1	Zai Lab Announces Pricing of Hong Kong Secondary Listing

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\108202\20-29356-9\task9883425\29356-9-ba.htm',USER='108202',CD='Sep 22 11:38 2020'

*SIGNATURES*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ZAI LAB LIMITED
By:	/s/ Billy Cho
Name:	Billy Cho
Title:	Chief Financial Officer

Date: September 22, 2020

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\108202\20-29356-9\task9883425\29356-9-ba.htm',USER='108202',CD='Sep 22 11:38 2020'